News
Researchers expand the potential of a virus for new cancer therapies and state-of-the-art vaccines
Researchers from IDIBELL and UB has identified two regions within the Vaccinia virus genome, where there would be enough space to introduce several genetic sequences in a stable way
Revolution in mental health: the transdiagnostic approach opens the door to new therapies applicable to more than one disorder at a time
A macro research confirms the genetic relationship between 14 different psychiatric disorders and groups them into five new families.
A patch inspired by mussels could help reduce relapse of the most aggressive brain tumor
A study with the participation of Bellvitge Campus proposes a new strategy to act directly in the place where the tumor has been extracted: a patch that sticks to the brain tissue and traps the residual tumor cells
Bellvitge promotes an innovative approach to minority epilepsy through advanced genetic diagnosis
A study by Bellvitge Hospital and IDIBELL describes a new genetic variant of a type of minority epilepsy
Research that changes the world from Bellvitge and at the hand of women scientists
Six active researchers from IDIBELL will engage in a dialectical duel at the 9th sLHam of Women Scientists
Science born from solidarity: Proyecto Tania and the Jut Contra el Cáncer Foundation contribute 51,000€ to the development of a new therapy against resistant colon cancer
The joint contribution will allow progress in a line of research that focuses on immunotherapy
Lung cancer uses the lack of nutrients to become stronger
The protein responsible for the adaptability of lung cancer, identified: when faced with a lack of nutrients and oxygen, the tumor secretes it and becomes aggressive
Being more active in the morning or at night can influence health and muscle strength
People with an afternoon chronotype have more difficulties in preserving a healthy muscles and metabolism.
ICO and IDIBELL lead an international study that guarantees the safety of a type of immunotherapy before transplantation
Bispecific antibodies are an immunotherapy that can be perfectly combined with bone marrow transplants in patients with lymphoma.